We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 24 APRIL 2017
Angiomax Patents Limited To Example
Foley & Lardner LLP
In The Medicines Co. v. Mylan, Inc., the Federal Circuit construed composition claims of two Angiomax patents as requiring the recited "batches" to be made by a specific "efficient mixing" process illustrated in one of the examples.
United StatesIntellectual Property









